Abstract
The primary tumors that typically cause carcinomatous meningitis include lung cancer, breast cancer, leukemia, lymphoma and melanoma. A variety of neurological signs and symptoms can be seen depending on the extent and location of the meningeal metastasis. Once the diagnosis of carcinomatous meningitis is confirmed, the search for the primary tumor can be a challenge and at times may require extensive radiographic or even surgical evaluation to obtain specimen for pathological confirmation. Here we report a patient who presented with bilateral cranial nerve VIII and cerebellar symptoms, and was diagnosed with carcinomatous meningitis. Only after an exploratory laporatomy did it become clear that the initial symptoms were related to a metastatic gallbladder carcinoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Tans RJ, Koudstaal J, Koehler PJ: Meningeal carcinomatosis as presenting symptom of a gallbladder carcinoma. Clin Neuro Neurosur 95: 253-256, 1993
Gaumann A, Marx J, Bohl J, Kommoss F, Kohler H, Tews DS: Leptomeningeal carcinomatosis and cranial nerve palsy as presenting symptoms of a clinically inapparent gallbladder carcinoma. Pathol Res Pract 195(7): 495-499, 1999
Higes-Pascual F, Beroi-Groh P, Bravo-Guillen AL, Palomo-Martinez V, Cuevas-Santos J: Leptomeningeal carcinomatosis as presenting symptoms of a gallbladder carcinoma. Rev Neurol 30(9): 841-844, 2000
Homa K, Hamashima H: Fulminating gallbladder carcinoma presenting as leptomeningeal carcinomatois and acute renal failure. Wien Klin Wochenschr 102: 654-656, 1990
Naylor RA, MacGregor JE, Hutcheon AW, Best PV: Meningeal carcinomatosis from clinically undiagnosed signet-ring cell primary in the gallbaldder. Surg Neurol 29: 315-318, 1988
Zachariah B, Zachariah SB, Varghese R, Balducci L: Review: carcinomatous megingitis: clinical manifestations and management. Int J Clin Pharmacol Ther 33(1): 7-12, 1995
Posner JB, Asbury AK, McKhann GM, McDonald WI: Secondary neoplastic disease. In: Disease of the Nervous System: Clinical Neurobiology, 2nd ed. 1992, pp 1093-1141
Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastasis from solid tumors: experience with 90 patients. Cancer 2: 759-772, 1982
Bakri YL, Lewis JJ, Lublin GCJ, Dannof B: Meningeal carcinomatosis complicating gynecologic malignancies: a literature review and report of a case. Obst Gynecol Sur 38: 1-5, 1983
Aboulafia DM, Taylor LP, Crane RD, Yon JL, Rudolph RH: Case report: carcinomatous meningitis complicating cervical cancer: a clinicopathologic study and literature review. Gynecol Oncol 60: 313-318, 1996
Crino PB, Sater RA, Sperling M, Katestos C: Renal cell carcinomatous meningitis: pathologic and immunochemical features. Neurol 45: 189-191, 1995
Deeb LS, Yamout BI, Shamseddine AL, Shabb NS, Uthman SM: Case Report: Meningeal carcinomatosis as the presenting manifestation of gastric adenocarcinoma. Am J Gastroenterol 92(2): 329-331, 1997
Chamberlain MC: Current concepts in leptomeningeal metastasis. Curr Opin Oncol 4: 533-539, 1992
Chamberlain MC, Sandy AD, Press GA: Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain. Neurology 40(3 Pt 1): 435-438, 1990
Freilich RJ, Krol G, DeAngelis LM: Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 38: 51-57, 1995
Jaeckle KA, Batchelor T, O 'Day SJ, Phuphanich S, New P, Lesser G, Cohn A, Gilbert M, Aiken R, Herons D, Rogers L, Wong E, Fulton D, Gutheil JC, Baidas S, Kennedy JM, Mason W, Moots P, Russell C, Swinnen LJ, Howell SB: An open-label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis. J Neurooncol 57(3): 231-239, 2002
Hitchins RN, Bell DR, Woods RL: A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 5: 1655-1662, 1987
Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS: Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Oncol 11: 561-568, 1993
Tetef ML, Margolin KA, Doroshow JH, Akman S, Leong LA, Morgan RJ Jr, Raschko JW, Slatkin N, Somlo G, Longmate JA, Carroll MI, Newman EM: Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis. Cancer Chemother Pharmacol 46: 19-26, 2000
Chamberlain MC, Kormanik PA, Barba D: Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. J Neurosurg 87: 694-699, 1997
Grant R, Naylor B, Greenberg HS, Junck L: Clinical outcome in aggressively treated meningeal carcinomatosis. Arch Neurol 51: 457-461, 1994
North JJ, Pack MS, Hong C, Rivera DE: Prognostic factors for adenocarcinoma of the gallbladder: an analysis of 162 cases. Am Surg 64(5): 43-440, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shen, Y., Blumenthal, D.T., Digre, K. et al. Carcinomatous Meningitis as the Presenting Manifestation of Gallbladder Carcinoma: Case Report and Review of the Literature. J Neurooncol 70, 67–71 (2004). https://doi.org/10.1023/B:NEON.0000040822.12161.35
Issue Date:
DOI: https://doi.org/10.1023/B:NEON.0000040822.12161.35